Description

8-(Bromomethyl)-2,3-Dimethyl-7,8-Dihydro-4H-[1,3]Thiazolo[3,2-A]Thieno[3,2-E]Pyrimidin-4-One is a high-purity, advanced pharmaceutical intermediate with a complex fused heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities and specialty fine chemicals.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, especially those targeting central nervous system (CNS) disorders or possessing complex heterocyclic pharmacophores.
• Organic Synthesis Building Block: Used in research and development for constructing complex fused-ring systems common in medicinal chemistry.
• Agrochemical Research: Serves as a starting material for developing new active ingredients with potential herbicidal or pesticidal activity.
• Material Science Research: Investigated for the development of organic electronic materials due to its electron-rich thiophene and pyrimidine components.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	8-(Bromomethyl)-2,3-Dimethyl-7,8-Dihydro-4H-[1,3]Thiazolo[3,2-A]Thieno[3,2-E]Pyrimidin-4-One
CAS No.	284687-86-1
Molecular Formula	C12H11BrN2OS2
Molecular Weight	343.26 g/mol
Synonyms	8-(Bromomethyl)-2,3-dimethyl-4H,7H,8H-[1,3]thiazolo[3,2-a]thieno[3,2-e]pyrimidin-4-one; 8-(Bromomethyl)-2,3-dimethyl-7,8-dihydro-4H-[1,3]thiazolo[3,2-a]thieno[3,2-e]pyrimidin-4-one; Thiazolo[3,2-a]thieno[3,2-e]pyrimidin-4-one, 8-(bromomethyl)-2,3-dimethyl-7,8-dihydro-; 284687-86-1; 8-Bromomethyl-2,3-dimethyl-7,8-dihydro-4H-[1,3]thiazolo[3,2-a]thieno[3,2-e]pyrimidin-4-one
EINECS	Contact for details

Quality Control

Our 8-(Bromomethyl)-2,3-Dimethyl-7,8-Dihydro-4H-[1,3]Thiazolo[3,2-A]Thieno[3,2-E]Pyrimidin-4-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the stringent requirements for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep the container sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.